How to Help Your Patients Find Vaxchora in Stock: A Provider's Guide

How to Help Your Patients Find Vaxchora in Stock: A Provider's Guide

When you recommend Vaxchora (Vibrio Cholerae Cvd 103-Hgr Strain Live Antigen) for a patient traveling to a cholera-affected area, you may be setting them up for a frustrating search. As the only FDA-approved cholera vaccine in the United States, Vaxchora is essential for pre-travel protection — but its limited retail availability means many patients struggle to find it.

This guide provides a practical workflow for helping your patients locate and access Vaxchora efficiently.

Current Availability Landscape

Understanding where Vaxchora is and isn't available will help you set appropriate expectations with patients:

Where Vaxchora Is Typically Available

• Travel health clinics: The most reliable source. Dedicated travel medicine practices routinely stock Vaxchora and have the infrastructure to reconstitute and administer it.
• Hospital pharmacies: Academic medical centers and large hospital systems with travel medicine or infectious disease departments.
• Public health departments: Some county and state health departments with travel health services.
• Military treatment facilities: For eligible patients, military health facilities may stock travel vaccines including Vaxchora.

Where Vaxchora Is Rarely Available

• Major chain pharmacies: CVS, Walgreens, Rite Aid, and similar chains rarely carry Vaxchora due to low demand.
• Urgent care centers: Not typically stocked.
• Primary care offices: Most do not maintain inventory of specialty travel vaccines.

Why Patients Can't Find Vaxchora

When patients report difficulty finding Vaxchora, the root causes are typically:

1. Low domestic demand: Only ~6 cholera cases per year in the US, so retail stocking makes little commercial sense.
2. Single manufacturer: Emergent Travel Health Inc. is the sole producer, with no generic or alternative FDA-approved product.
3. Cold chain and preparation requirements: Must be refrigerated (36-46°F), reconstituted with purified bottled water in a healthcare setting, and consumed within hours.
4. Cost deterrent: At $295-$373 per dose, some patients delay or abandon their search, especially if insurance doesn't cover it.
5. Late planning: Patients often seek the vaccine too close to departure, limiting options when their first choice is unavailable.

What Providers Can Do: 5 Steps

Step 1: Discuss Cholera Vaccination Early

Bring up Vaxchora at the first pre-travel consultation, ideally 4-6 weeks before departure. Explain that the vaccine needs to be taken at least 10 days before potential exposure and that finding it may require extra time.

Provide patients with a clear timeline:

• Weeks 4-6: Begin searching for Vaxchora
• Week 3: Secure appointment at a travel clinic or pharmacy with stock
• Week 2+: Receive vaccination (≥10 days before departure)

Step 2: Direct Patients to the Right Locations

Rather than sending patients to their neighborhood pharmacy, point them toward:

• Travel health clinics in your area
• Hospital travel medicine departments
• Medfinder for Providers: Use medfinder.com/providers to check availability and share results with your patient

If your practice has the capability to stock and administer Vaxchora, consider adding it to your vaccine inventory, particularly if you see a significant volume of pre-travel patients.

Step 3: Provide a Written Order or Prescription

Give patients a written prescription or vaccine order they can present at any administering location. Include:

• Vaccine name: Vaxchora (Cholera Vaccine, Live, Oral)
• NDC: 70460-004-01
• Dose: Single oral dose, 100 mL (50 mL for ages 2-5)
• Clinical indication: Pre-travel cholera prophylaxis
• Travel destination and dates

A documented clinical indication may help with insurance coverage, as some plans cover travel vaccines as a medical benefit.

Step 4: Address Cost Concerns Proactively

Be upfront about the cost. Vaxchora runs $295-$373 per dose. Help patients by:

• Suggesting they check insurance coverage (may be covered as a medical benefit, not pharmacy benefit)
• Recommending discount cards like SingleCare (~$295)
• Noting that some employer plans and travel insurance policies cover pre-travel vaccinations
• Directing financially strained patients to NeedyMeds or RxAssist

For a patient-facing resource, share our article on how to save money on Vaxchora.

Step 5: Have a Backup Plan

If Vaxchora truly cannot be obtained before departure:

• Provide comprehensive counseling on food and water safety precautions
• Prescribe or recommend oral rehydration salts for the travel kit
• Discuss whether the patient's itinerary includes countries where Dukoral or other WHO-approved cholera vaccines are available
• Document the conversation and your clinical reasoning in the chart

Therapeutic Alternatives

While there is no FDA-approved alternative to Vaxchora in the United States, providers should be aware of internationally available options:

• Dukoral: Inactivated oral cholera vaccine with recombinant B subunit. Two-dose regimen. Available in Canada, Europe, Australia. Not FDA-approved.
• Shanchol: Bivalent inactivated oral cholera vaccine (O1 and O139). Two-dose regimen. Used in WHO mass vaccination campaigns. Not FDA-approved.
• Euvichol-Plus: Equivalent to Shanchol. Produced in South Korea. Most widely used in WHO global stockpile. Not FDA-approved.

For patients with complex itineraries, vaccination at an international stop may be a viable contingency.

Workflow Tips for Your Practice

• Create a travel vaccine checklist that includes Vaxchora sourcing alongside other pre-travel vaccines (yellow fever, typhoid, hepatitis A, etc.)
• Maintain a list of local travel health clinics and their contact information to share with patients
• Set up a Medfinder provider account at medfinder.com/providers for streamlined availability checks
• Consider stocking Vaxchora if your practice volume justifies it — the vaccine has a shelf life that makes it practical for clinics seeing regular pre-travel patients
• Document early: Note the cholera vaccination discussion and recommendation in the chart at the first visit, so there's a clear record even if the patient obtains the vaccine elsewhere

Final Thoughts

Helping patients find Vaxchora is often as important as recommending it. By discussing cholera vaccination early, directing patients to the right locations, providing actionable resources like Medfinder for Providers, and having contingency plans ready, you can significantly improve your patients' chances of getting vaccinated on time.

For the patient perspective on shortage and availability, see our companion article: Vaxchora shortage update for patients. For more provider resources, see our article on what providers need to know about the Vaxchora shortage in 2026.